ArticleEuropean thyroid journal2026
Newborn screening for congenital hypothyroidism in France: a study of current professional practices.
Article in European thyroid journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Congenital hypothyroidism is a leading cause of preventable intellectual disability. Neonatal screening enables early detection and treatment, ideally before symptoms appear. In France, screening has been part of national public health policy since 1978, relying on standardized protocols to ensure equity of care. However, the actual adherence to these guidelines and potential local adaptations remain undocumented. This study aimed to describe current practices of French Regional Neonatal Screening Centers and assess their conformity with national recommendations. Methods: In 2024, a cross-sectional descriptive survey was conducted via a structured online questionnaire sent to all 16 French Regional Neonatal Screening Centers. The questionnaire addressed TSH retesting and referral thresholds, use of thyroxine assays, second-tier testing, resampling protocols, and management of preterm infants. Data were analyzed to identify deviations from guidelines and their potential implications. Results: All 16 centers responded (100% response rate). Nine (56%) reported deviations from national recommendations. Five centers applied alternative TSH retesting or referral thresholds. Four measured thyroxine on the first dried blood spot for intermediate TSH levels, with one retrospectively evaluating this approach. Three centers had specific resampling protocols for preterm infants, but none used gestational age-adjusted TSH thresholds. These adaptations aimed to reduce false positives and false negatives associated with the standard protocol. Conclusion: This nationwide survey highlights substantial heterogeneity in congenital hypothyroidism screening practices across France. Variations in TSH thresholds, thyroxine measurement, and preterm infant management may impact diagnostic consistency and equity. Harmonization efforts based on evidence are needed to optimize neonatal screening performance nationally.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.